Product Information
TOBRAMYCIN 0.3% EYE DROP is a generic product labeled by Sandoz Inc., priced at $1.1081 per ML under NDC 61314064305. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 13, 1984. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Sandoz Inc.NDC
61314064305
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062535FDA Approved
12/13/1984
TE Code
AT
On Market Since
1/9/1995
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 0.3% EYE DROP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1081 per ML |
|---|---|
| All-time high | $1.8050 (Sep 14, 2022) |
| All-time low | $0.7286 (Jul 17, 2024) |
| 52-week high | $1.1579 |
| 52-week low | $1.0024 |
| Median price | $1.3266 |
| Average price | $1.3082 |
| Largest weekly change | +63.0% (Jun 19, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tobramycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 0.3% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 0.3% EYE DROP, manufactured by Sandoz Inc., is $1.1081 per ML (NDC 61314064305), effective Sep 30, 2026.
How has the price of TOBRAMYCIN 0.3% EYE DROP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 0.3% EYE DROP has declined 26.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 0.3% EYE DROP?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN 0.3% EYE DROP has ranged from a low of $0.7286 (Jul 17, 2024) to a high of $1.8050 (Sep 14, 2022), with a median of $1.3266 per ML.
Are there cheaper alternatives to TOBRAMYCIN 0.3% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOBRAMYCIN 0.3% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRAMYCIN 0.3% EYE DROP?
TOBRAMYCIN 0.3% EYE DROP (NDC 61314064305) is labeled by Sandoz Inc., and CMS classifies it as a generic product.